Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Regains Compliance with Nasdaq Rule

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker said in a filing with the US Securities and Exchange Commission today that it has regained compliance with certain Nasdaq regulations.

The firm received a letter from Nasdaq on March 25, informing it that it was not in compliance with the stock market's rule that a firm must have at least three independent directors on its audit committee. The letter came after Bruker announced that Collin D'Silva, an independent director and member of the firm's audit committee, had resigned.

Nasdaq sent another letter to Bruker on April 1, which informed the firm that it also was not in compliance with a rule that the majority of its board must be comprised of independent directors.

The firm regained compliance with both rules after its election last week of Charles Wagner to serve on its board and its audit committee. Wagner most recently served as CFO of Millipore, prior to that firm's acquisition by Merck KGaA.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.